Neuraxpharm (DE)

https://www.neuraxpharm.de

Created in August 2016, following the acquisition by funds advised by Apax Partners, the Group Invent Farma / neuraxpharm is a leader in generic pharmaceutical products for the treatment of disorders of the central nervous system (CNS). The Group is the combination of the Barcelona-based Invent Farma with Düsseldorf-based neuraxpharm. Invent Farma has 50 years’ experience in the development, manufacturing and marketing of pharmaceutical products, while neuraxpharm is a leading CNS brand that has earned the trust of specialist doctors, pharmacists and patients in over three decades. The Group markets, through Qualigen and neuraxpharm, generics drugs from a combined portfolio of predominantly differentiated products mainly in the CNS field. In addition, the Group owns and operates two manufacturing plants in Spain: one of the plants to produce hard-to-make active pharmaceutical ingredients (APIs) with a unique expertise in the respiratory area (Inke), and the other one to produce finished dosage forms (FDFs) across multiple therapeutic areas (Lesvi). *

	Start	2016-08-01 existent
	Group	NuPharm (Group)
	Today	Invent Farma Holding Spain S.L.
	Industry	CNS drug (neurological drug)
	Industry 2	DRUGS, GENERICS

	Region	Düsseldorf
	Country	Germany
	City	n. a. Düsseldorf
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf.

		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for NuPharm (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)